Prize-Based Incentives for Smoking Cessation Among People With HIV: A Sequential Multiple Assignment Randomized Trial

被引:2
|
作者
Ledgerwood, David M. [1 ]
Lundahl, Leslie H. [1 ]
Greenwald, Mark K. [1 ]
Cohn, Jonathan [2 ]
Arfken, Cynthia L. [1 ]
机构
[1] Wayne State Univ, Dept Psychiat & Behav Neurosci, Ste 2C,3901 Chrysler Dr, Detroit, MI 48201 USA
[2] Wayne State Univ, Dept Internal Med, Div Infect Dis, Detroit, MI 48201 USA
关键词
QUALITY-OF-LIFE; CONTINGENCY MANAGEMENT; TOBACCO USE; SMOKERS; INTERVENTIONS; ABSTINENCE; DEPENDENCE; VARENICLINE; EFFICACY; USERS;
D O I
10.1093/ntr/ntae243
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Introduction: Contingency management (CM) is an incentive-based approach that has demonstrated efficacy for smoking cessation in various populations. There is an unmet need for feasible and effective smoking cessation interventions in people with HIV (PWH). The purpose of this study was to assess the efficacy of prize-based CM for smoking cessation in PWH using a Sequential Multiple Assignment Randomization Trial (SMART) design selected to tailor intervention intensity based on early treatment response. Methods: During phase I, 129 participants were randomly assigned to high-magnitude prize CM (HM-CM) or standard of care (SoC) for 4 weeks. Participants who did not reduce smoking were randomized in phase II to continued counseling with HM-CM plus monitoring support or only continued monitoring support for 8 weeks. Participants who reduced smoking were randomized to booster monitoring with low-magnitude CM or no additional care. Outcomes were biochemically verified smoking reduction and 7-day abstinence prevalence at posttreatment, 6-month, and 12-month follow-up. Results: Phase I responders (based on biochemical indicators of smoking reduction) were significantly less likely to return to smoking (during treatment and at 6 and 12 months) if they received low-magnitude incentives. Notably, initial exposure to CM versus SoC did not increase the rate of phase I response, and high-magnitude incentives later in treatment did not lead to greater smoking cessation for early-treatment nonresponders. Conclusions: Weekly CM sessions in the first 4 weeks of smoking cessation intervention did not perform significantly better than SoC. However, brief booster CM sessions aimed at maintaining early smoking cessation hold clinical promise and warrant further investigation. Implications: This represents the first trial to examine the use of CM for smoking cessation among PWH within the context of a SMART design.
引用
收藏
页码:893 / 902
页数:10
相关论文
共 50 条
  • [21] A Sequential Multiple Assignment Randomized Trial of Symptom Management After Chemotherapy
    Sikorskii, Alla
    Badger, Terry
    Segrin, Chris
    Crane, Tracy E.
    Chalasani, Pavani
    Arslan, Waqas
    Hadeed, Mary
    Morrill, Kristin E.
    Given, Charles
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2023, 65 (06) : 541 - +
  • [22] Optimization of behavioral dynamic treatment regimens based on the sequential, multiple assignment, randomized trial (SMART)
    Collins, Linda M.
    Nahum-Shani, Inbal
    Almirall, Daniel
    CLINICAL TRIALS, 2014, 11 (04) : 426 - 434
  • [23] A pilot randomized controlled trial of a tailored smoking cessation program for people living with HIV in the Washington, DC metropolitan area
    Kierstead, Elexis C.
    Harvey, Emily
    Sanchez, Denisse
    Horn, Kimberly
    Abroms, Lorien C.
    Spielberg, Freya
    Stanton, Cassandra A.
    Debnam, Charles
    Cohn, Amy M.
    Gray, Tiffany
    Magnus, Manya
    Patel, Minal
    Niaura, Raymond
    Elf, Jessica L.
    BMC RESEARCH NOTES, 2021, 14 (01)
  • [24] Use of Non-Assigned Smoking Cessation Programs Among Participants of a Web-Based Randomized Controlled Trial
    Danaher, Brian G.
    Lichtenstein, Edward
    McKay, H. Garth
    Seeley, John R.
    JOURNAL OF MEDICAL INTERNET RESEARCH, 2009, 11 (02)
  • [25] Mobile contingency management for smoking cessation among socioeconomically disadvantaged adults: Protocol for a randomized trial
    Kendzor, Darla E.
    Businelle, Michael S.
    Vidrine, Damon J.
    Frank-Pearce, Summer G.
    Shih, Ya-Chen Tina
    Dallery, Jesse
    Alexander, Adam C.
    Boozary, Laili Kharazi
    Waring, Joseph J. C.
    Ehlke, Sarah J.
    CONTEMPORARY CLINICAL TRIALS, 2022, 114
  • [26] Effectiveness of a smoking cessation algorithm integrated into HIV primary care: Study protocol for a randomized controlled trial
    McKetchnie, Samantha M.
    O'Cleirigh, Conall
    Crane, Heidi M.
    Hill, Samantha, V
    Prior, David
    Peretti, Matteo
    Parman, Mariel
    Levy, Douglas E.
    Long, Dustin
    Cropsey, Karen
    CONTEMPORARY CLINICAL TRIALS, 2021, 110
  • [27] Predictors of Smoking Cessation Among College Students in a Pragmatic Randomized Controlled Trial
    Pardavila-Belio, Miren I.
    Ruiz-Canela, Miguel
    Canga-Armayor, Navidad
    PREVENTION SCIENCE, 2019, 20 (05) : 765 - 775
  • [29] Randomized Controlled Trial Examining the Efficacy of Adding Financial Incentives to Best practices for Smoking Cessation Among pregnant and Newly postpartum Women
    Higgins, Stephen T.
    Nighbor, Tyler D.
    Kurti, Allison N.
    Heil, Sarah H.
    Slade, Eric P.
    Shepard, Donald S.
    Solomon, Laura J.
    Lynch, Mary Ellen
    Johnson, Harley K.
    Markesich, Catherine
    Rippberger, Peter L.
    Skelly, Joan M.
    DeSarno, Michael
    Bunn, Janice
    Hammond, Jessie B.
    Roemhildt, Maria L.
    Williams, Rhonda K.
    O'Reilly, Deirdre M.
    Bernstein, Ira M.
    PREVENTIVE MEDICINE, 2022, 165
  • [30] A Randomized Clinical Trial of Nicotine Preloading for Smoking Cessation in People with Posttraumatic Stress Disorder
    Dedert, Eric A.
    Dennis, Paul A.
    Calhoun, Patrick S.
    Dennis, Michelle F.
    Beckham, Jean C.
    JOURNAL OF DUAL DIAGNOSIS, 2018, 14 (03) : 148 - 157